
### [MONDO:0015757](http://purl.obolibrary.org/obo/MONDO_0015757)
**Label:** lymphoid hemopathy

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0017595](http://purl.obolibrary.org/obo/MONDO_0017595) (aggressive b-cell non-Hodgkin lymphoma), [MONDO:0019754](http://purl.obolibrary.org/obo/MONDO_0019754) (multicentric Castleman disease), [MONDO:0011495](http://purl.obolibrary.org/obo/MONDO_0011495) (Langerhans-cell histiocytosis), [MONDO:0017594](http://purl.obolibrary.org/obo/MONDO_0017594) (indolent b-cell non-Hodgkin lymphoma), [MONDO:0007926](http://purl.obolibrary.org/obo/MONDO_0007926) (Waldenstrom macroglobulinemia), [MONDO:0000432](http://purl.obolibrary.org/obo/MONDO_0000432) (lymphoplasmacytic lymphoma), [MONDO:0020325](http://purl.obolibrary.org/obo/MONDO_0020325) (anaplastic large cell lymphoma), [MONDO:0020081](http://purl.obolibrary.org/obo/MONDO_0020081) (macrophage or histiocytic tumor), [MONDO:0020082](http://purl.obolibrary.org/obo/MONDO_0020082) (dendritic cell tumor), [MONDO:0004952](http://purl.obolibrary.org/obo/MONDO_0004952) (Hodgkins lymphoma), [MONDO:0005587](http://purl.obolibrary.org/obo/MONDO_0005587) (non-Hodgkins lymphoma), [MONDO:0020083](http://purl.obolibrary.org/obo/MONDO_0020083) (immunodeficiency-associated lymphoproliferative disease), [MONDO:0015819](http://purl.obolibrary.org/obo/MONDO_0015819) (indolent primary cutaneous b-cell lymphoma), [MONDO:0015818](http://purl.obolibrary.org/obo/MONDO_0015818) (aggressive primary cutaneous b-cell lymphoma), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0015759](http://purl.obolibrary.org/obo/MONDO_0015759) (b-cell non-Hodgkin lymphoma), [MONDO:0018908](http://purl.obolibrary.org/obo/MONDO_0018908) (non-Hodgkin lymphoma), [MONDO:0005062](http://purl.obolibrary.org/obo/MONDO_0005062) (lymphoma), [MONDO:0018905](http://purl.obolibrary.org/obo/MONDO_0018905) (diffuse large b-cell lymphoma), [MONDO:0015817](http://purl.obolibrary.org/obo/MONDO_0015817) (aggressive primary cutaneous T-cell lymphoma), [MONDO:0018906](http://purl.obolibrary.org/obo/MONDO_0018906) (follicular lymphoma), [MONDO:0015816](http://purl.obolibrary.org/obo/MONDO_0015816) (indolent primary cutaneous T-cell lymphoma), [MONDO:0017979](http://purl.obolibrary.org/obo/MONDO_0017979) (autoimmune lymphoproliferative syndrome), [MONDO:0015758](http://purl.obolibrary.org/obo/MONDO_0015758) (primary cutaneous T-cell lymphoma), [MONDO:0020080](http://purl.obolibrary.org/obo/MONDO_0020080) (histiocytic and dendritic cell tumor), [MONDO:0015564](http://purl.obolibrary.org/obo/MONDO_0015564) (Castleman disease), [MONDO:0015820](http://purl.obolibrary.org/obo/MONDO_0015820) (primary cutaneous b-cell lymphoma), [MONDO:0018897](http://purl.obolibrary.org/obo/MONDO_0018897) (primary cutaneous CD30+ T-cell lymphoproliferative disease), [MONDO:0018898](http://purl.obolibrary.org/obo/MONDO_0018898) (primary cutaneous lymphoma), [MONDO:0018310](http://purl.obolibrary.org/obo/MONDO_0018310) (Langerhans cell histiocytosis), [MONDO:0015760](http://purl.obolibrary.org/obo/MONDO_0015760) (T-cell non-Hodgkin lymphoma), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0019463](http://purl.obolibrary.org/obo/MONDO_0019463) (non-amyloid monoclonal immunoglobulin deposition disease), [MONDO:0020079](http://purl.obolibrary.org/obo/MONDO_0020079) (plasma cell tumor), [MONDO:0019464](http://purl.obolibrary.org/obo/MONDO_0019464) (heavy chain disease), [MONDO:0009348](http://purl.obolibrary.org/obo/MONDO_0009348) (classic Hodgkin lymphoma), [MONDO:0005615](http://purl.obolibrary.org/obo/MONDO_0005615) (plasmacytoma), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), [MONDO:0004967](http://purl.obolibrary.org/obo/MONDO_0004967) (acute lymphoblastic leukemia (disease)), [MONDO:0004963](http://purl.obolibrary.org/obo/MONDO_0004963) (T-cell acute lymphoblastic leukemia), [MONDO:0017604](http://purl.obolibrary.org/obo/MONDO_0017604) (marginal zone lymphoma), [MONDO:0017207](http://purl.obolibrary.org/obo/MONDO_0017207) (primary organ-specific lymphoma), [MONDO:0015821](http://purl.obolibrary.org/obo/MONDO_0015821) (mycosis fungoides and variants), 

**Corr. equiv. classes:** [Orphanet:178548](http://www.orpha.net/ORDO/Orphanet_178548), [Orphanet:300846](http://www.orpha.net/ORDO/Orphanet_300846), [Orphanet:33226](http://www.orpha.net/ORDO/Orphanet_33226), [Orphanet:160](http://www.orpha.net/ORDO/Orphanet_160), [Orphanet:300842](http://www.orpha.net/ORDO/Orphanet_300842), [OMIM:153600](http://purl.obolibrary.org/obo/OMIM_153600), [OMIM:613065](http://purl.obolibrary.org/obo/OMIM_613065), [OMIM:247640](http://purl.obolibrary.org/obo/OMIM_247640), [OMIM:613067](http://purl.obolibrary.org/obo/OMIM_613067), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [OMIM:613024](http://purl.obolibrary.org/obo/OMIM_613024), [OMIM:610430](http://purl.obolibrary.org/obo/OMIM_610430), [Orphanet:171901](http://www.orpha.net/ORDO/Orphanet_171901), [OMIM:609630](http://purl.obolibrary.org/obo/OMIM_609630), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [Orphanet:93686](http://www.orpha.net/ORDO/Orphanet_93686), [Orphanet:513](http://www.orpha.net/ORDO/Orphanet_513), [OMIM:246400](http://purl.obolibrary.org/obo/OMIM_246400), [Orphanet:99860](http://www.orpha.net/ORDO/Orphanet_99860), [OMIM:604856](http://purl.obolibrary.org/obo/OMIM_604856), [Orphanet:178557](http://www.orpha.net/ORDO/Orphanet_178557), [OMIM:186770](http://purl.obolibrary.org/obo/OMIM_186770), [Orphanet:98293](http://www.orpha.net/ORDO/Orphanet_98293), [OMIM:605027](http://purl.obolibrary.org/obo/OMIM_605027), [Orphanet:3261](http://www.orpha.net/ORDO/Orphanet_3261), [Orphanet:86864](http://www.orpha.net/ORDO/Orphanet_86864), [Orphanet:178551](http://www.orpha.net/ORDO/Orphanet_178551), [Orphanet:391](http://www.orpha.net/ORDO/Orphanet_391), [Orphanet:98290](http://www.orpha.net/ORDO/Orphanet_98290), [Orphanet:178554](http://www.orpha.net/ORDO/Orphanet_178554), [Orphanet:86861](http://www.orpha.net/ORDO/Orphanet_86861), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [Orphanet:171915](http://www.orpha.net/ORDO/Orphanet_171915), [OMIM:148000](http://purl.obolibrary.org/obo/OMIM_148000), [Orphanet:547](http://www.orpha.net/ORDO/Orphanet_547), [OMIM:400021](http://purl.obolibrary.org/obo/OMIM_400021), [Orphanet:223735](http://www.orpha.net/ORDO/Orphanet_223735), [Orphanet:544](http://www.orpha.net/ORDO/Orphanet_544), [Orphanet:98289](http://www.orpha.net/ORDO/Orphanet_98289), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [Orphanet:389](http://www.orpha.net/ORDO/Orphanet_389), [Orphanet:171918](http://www.orpha.net/ORDO/Orphanet_171918), [Orphanet:98841](http://www.orpha.net/ORDO/Orphanet_98841), [OMIM:236000](http://purl.obolibrary.org/obo/OMIM_236000), [Orphanet:545](http://www.orpha.net/ORDO/Orphanet_545), [Orphanet:542](http://www.orpha.net/ORDO/Orphanet_542), [Orphanet:98287](http://www.orpha.net/ORDO/Orphanet_98287), [Orphanet:98288](http://www.orpha.net/ORDO/Orphanet_98288), [Orphanet:541](http://www.orpha.net/ORDO/Orphanet_541), [OMIM:300221](http://purl.obolibrary.org/obo/OMIM_300221), [Orphanet:98282](http://www.orpha.net/ORDO/Orphanet_98282), [Orphanet:86855](http://www.orpha.net/ORDO/Orphanet_86855), [Orphanet:178566](http://www.orpha.net/ORDO/Orphanet_178566), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [Orphanet:178563](http://www.orpha.net/ORDO/Orphanet_178563), [OMIM:151400](http://purl.obolibrary.org/obo/OMIM_151400), [OMIM:601859](http://purl.obolibrary.org/obo/OMIM_601859), [OMIM:603909](http://purl.obolibrary.org/obo/OMIM_603909), [OMIM:615545](http://purl.obolibrary.org/obo/OMIM_615545), [OMIM:612558](http://purl.obolibrary.org/obo/OMIM_612558), [OMIM:612557](http://purl.obolibrary.org/obo/OMIM_612557), [OMIM:612559](http://purl.obolibrary.org/obo/OMIM_612559), [OMIM:109543](http://purl.obolibrary.org/obo/OMIM_109543), [Orphanet:300912](http://www.orpha.net/ORDO/Orphanet_300912), [Orphanet:29073](http://www.orpha.net/ORDO/Orphanet_29073), [OMIM:615559](http://purl.obolibrary.org/obo/OMIM_615559), [Orphanet:279911](http://www.orpha.net/ORDO/Orphanet_279911), [Orphanet:314701](http://www.orpha.net/ORDO/Orphanet_314701), 

**Class expressions from DL-Learner:**

- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 30.58%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 29.80%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 25.82%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 25.55%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 23.33%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 22.85%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 22.82%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 22.79%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 22.78%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 22.78%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 22.78%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 21.94%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 20.87%
- Thing 20.84%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 20.84%


